Rising Losses Weigh on Rigetti's Outlook: Sell or Hold RGTI Stock Now?

Rigetti shares fell 10.5% over the past month, underperforming IonQ (-4.9%) and Quantum Computing Inc. (-8.0%) as investors question the timeline for commercial quantum adoption. Q2 revenue rose 185.3% year over year to $5.1 million, but operating expenses increased 48% to $30.3 million and operating loss widened to $28.1 million from $19.9 million. Rigetti expects elevated 2026 capex and remains dependent on uneven government and system-contract revenue, while its 108-qubit system's roughly 99.1% two-qubit fidelity remains below long-term targets; Zacks rates the stock Strong Sell despite $541.3 million of cash and a potential, but nonbinding, $100 million CHIPS Act award.

Analysis

RGTI’s issue is not solvency but capital efficiency: a large cash balance can fund the roadmap, yet it also removes the near-term financing catalyst that would force spending discipline. The market is likely to value the company on proof points—fidelity, coherence, contracted backlog conversion, and repeatable cloud/on-premise utilization—rather than reported revenue, because individual system acceptances can distort quarterly growth. A delayed acceptance or a missed technical benchmark would therefore have an outsized valuation impact over the next 1-3 months.

Relative performance suggests the market is assigning a lower probability to Rigetti closing the superconducting-hardware execution gap than to IonQ’s trapped-ion approach. The more relevant competitive risk is not QUBT’s equity performance but that HPE and other HPC integrators can remain architecture-agnostic; partnership announcements do not imply durable hardware preference unless they produce recurring service revenue or follow-on deployments. Government support lowers development risk but can increase dependence on procurement cycles and restricted-use workloads rather than validate broad commercial demand.

Consensus may be too linear in extrapolating current losses: if CHIPS funding becomes definitive and offsets fabrication investment, RGTI could re-rate sharply because the market is positioned skeptically and the balance sheet provides runway. Conversely, the funding is not yet bankable, and a cash-funded capex cycle without measurable performance gains would turn the cash balance from a valuation floor into evidence of negative-return investment. The key 6-18 month question is whether technical progress reduces error-correction cost faster than operating expense growth; absent that, peer-relative multiple compression remains the likely path.

Key Decisions for Investors

• Maintain no core long exposure to RGTI ahead of the next system-acceptance and technical-update window; use any rally driven solely by non-binding funding or partnership headlines to reduce risk. Thesis is falsified positively by definitive CHIPS funding plus repeatable customer deployments or a material fidelity/coherence improvement.
• Express relative skepticism via long IONQ / short RGTI in equal dollar amounts over a 1-3 month horizon, sized modestly given high quantum-beta correlation. The trade targets further relative multiple compression in RGTI; stop if RGTI secures definitive non-dilutive funding and demonstrates a credible technical step-change ahead of IONQ.
• For HPE, treat quantum integration announcements as narrative-positive but financially immaterial; do not underwrite incremental earnings until orders disclose hardware, services, and recurring support economics. A measurable HPC services/backlog contribution is the required trigger for a standalone long thesis.
• Set alerts for definitive award terms, C-DAC acceptance, quarterly cash burn, and disclosed backlog/follow-on orders. A cash-burn acceleration without corresponding technical milestones is a short/add signal; accepted system revenue alone is not sufficient confirmation because installation-driven sales are episodic.